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Abstract
Background In the past decades, behavioral medicine has attained global recognition. Due to its global reach, a critical need has
emerged to consider whether the original definition of behavioral medicine is still valid, comprehensive, and inclusive, and to
reconsider the main tasks and goals of the International Society of Behavioral Medicine (ISBM), as the umbrella organization in
the field. The purpose of the present study was to (i) update the definition and scope of behavioral medicine and its defining
characteristics; and (ii) develop a proposal on ISBM’s main tasks and goals.
Method Our study used the Delphi method. A core group prepared a discussion paper. An international Delphi panel rated
questions and provided comments. The panel intended to reach an a priori defined level of consensus (i.e., 70%).
Results The international panel reached consensus on an updated definition and scope of behavioral medicine as a field of
research and practice that builds on collaboration among multiple disciplines. These disciplines are concerned with development
and application of behavioral and biomedical evidence across the disease continuum in clinical and public health domains.
Consensus was reached on a proposal for ISBM’s main tasks and goals focused on supporting communication and collaboration
across disciplines and participating organizations; stimulating research, education, and practice; and supporting individuals and
organizations in the field.
Conclusion The consensus on definition and scope of behavioral medicine and ISBM’s tasks and goals provides a foundational
step toward achieving these goals.
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Introduction
The field of behavioral medicine was originally defined at the
Yale Conference on behavioral medicine, now more than
40 years ago [1]. Behavioral medicine was defined as “the
interdisciplinary field concerned with the development and
integration of behavioral and biomedical science knowledge
and techniques relevant to health and illness and the applica-
tion of this knowledge and these techniques to prevention,
diagnosis, treatment and rehabilitation” [1]. The definition
was developed by a group of outstanding scholars from
North America, aiming to increase communications of theory,
research, and applications in the field, as well as to facilitate
access to research funding [2]. During those 40 years, the field
has significantly evolved and expanded, witnessing major sci-
entific discoveries and developments, e.g., the role of depres-
sion in cardiovascular disease [3], and the increasing emphasis
on behavior change in the prevention of disease [4]. In addi-
tion to basic science and clinical practice, the scope of
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behavioral medicine has since broadened to include public
health [5]. Behavioral medicine has attained global recogni-
tion. Due to its global reach, the field of behavioral medicine
currently faces the challenges and opportunities represented
by the many international differences in perspectives on health
and disease, implementation in a diversity of health care sys-
tems, and engagement across varied scientific traditions [6].
The International Society of Behavioral Medicine (ISBM),
a federation of 26 national societies with a shared focus on
behavioral science and behavioral medicine, promotes behav-
ioral science, research, education, and practice in a global
context, embracing the complexity and diversity of its mem-
ber organizations. Given the expanded scope and reach of
behavioral medicine, a critical need arose to consider whether
the original definition of behavioral medicine is still valid,
comprehensive, and inclusive. Issues to consider included
the meaning of the term “behavior,” the need to refer to
“health” in addition to “medicine,” the implications of the
increased emphasis on public health, the question whether
behavioral medicine is a field or a discipline, the implications
of the growing emphasis on the development and evaluation
of implementation strategies, and other issues [6, 7] (see also
Supplementary file 1).
Development of a preliminary proposal for an updated
definition and scope of behavioral medicine [6] led to
considerable discussion and debate [8–12], underscoring
the need to reconsider the original definition. The need
for further input from ISBM members was emphasized
[7]. A slightly revised proposal [7] was presented and
discussed at the International Congress of Behavioral
Medicine 2018, in the context of discussions on the main
tasks and goals, and future organization of ISBM. The
ISBM Board decided to install the ISBM Taskforce
“Definition, Goals and Organization” charged with the
task to develop a proposal on ISBM’s main tasks and
goals, and to take the updated definition and scope of
behavioral medicine and its defining characteristics as a
starting point. With the intent to understand and integrate
current cross-cultural and cross-disciplinary perspectives
on behavioral medicine in a global context, the purpose
of the present study was to (i) update the definition and
scope of behavioral medicine and its defining character-
istics; and (ii) develop a proposal on ISBM’s main tasks
and goals.
Method
Design Our study used the Delphi method. The design
was derived from a recent review of methods used in
Delphi studies [13]. A core group prepared a discussion
paper, identified items for discussion, and developed a
questionnaire. A Delphi panel rated the questions and
provided comments. Subsequently, the core group devel-
oped a proposal on how to proceed in the next round of
discussion. The panel intended to reach the a priori de-
fined level of consensus (i.e., 70%) in two to three
rounds of discussion.
Panel The Delphi panel consisted of the core group and rep-
resentatives of various organizations. Members of the core
group (AHB, MK, BL, JL, BM, UMN, FP, AS, DJW, and
the non-voting moderator/chair JD) were selected by the
ISBM Executive Committee. All ISBM member societies,
ISBM’s early career network (INSPIRE), and several emerg-
ing collaborative groups in the field of behavioral medicine
were invited to nominate a representative to the panel. The
following organizations nominated a representative:
American Psychosomatic Society, Australasian Society for
Behavioral Health and Medicine, Behavioral Medicine
Section of the Finnish Association of Social Medicine,
Chinese Society of Behavioural Medicine, Danish Society of
Psychosocial Medicine, Division of Behavioural Medicine of
the Cuban Society of Health Psychology, German College of
Psychosomatic Medicine, German Society of Behavioral
Medicine and Behavior Modification, Hong Kong Society
of Behavioral Health, Hungarian Society of Behavioral
Sciences and Medicine, Japanese Society of Behavioral
Medicine, Netherlands Behavioral Medicine Federation,
Norwegian Society of Behavioral Medicine, Portuguese
Society of Health and Behavior, Society of Behavioural
Health Singapore, Society of Behavioral Medicine (USA),
Swedish Behavioral Medicine Society, UK Society of
Behavioral Medicine, INSPIRE, and emerging collaborative
groups on behavioral medicine in China and Thailand (and
another representative of an emerging collaborative group,
who did not respond in any of the Delphi rounds).
Discussion Paper The core group prepared a discussion paper,
drawing on previous publications [1, 5–12], previous discus-
sions at the ISBM Governing Council meeting and a session
held at the International Congress of Behavioral Medicine
(Santiago, November 2018) [14]. The discussion paper is in
Supplementary file 1.
Items for Discussion, Questionnaire, and Procedure In round
1, based on the discussion paper, the core group defined 9
items for discussion, resulting in 10 questions (a question on
each item, and an open question) (see Supplementary file 2).
In round 2, the core group defined 3 items for discussion (see
Supplementary file 2). In rounds 3 and 4, the core group de-
fined 1 item for discussion (see Supplementary file 2). The
Delphi panel (consisting of the core group and the represen-
tatives) rated the questions on a 5-point Likert scale (strongly
agree, agree, neutral, disagree, strongly disagree). The need
for strong input from the panel was emphasized throughout
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the entire Delphi study. In round 1, the panel members were
invited to bring up additional items for discussion. In all
rounds, they were encouraged to make proposals on the def-
inition and scope of behavioral medicine, the defining charac-
teristics, and main tasks and goals, and to provide comments
on each item/question.
Questionnaire Rounds, Consensus, and Feedback The study
was designed to have two to three rounds of discussion, de-
pending on how soon consensus would be reached. The a
priori consensus level was set at 70% of respondents’ voting
in the strongly agree/agree (or disagree/strongly disagree) cat-
egories. The moderator summarized the responses in each
round and the core group then made proposals on items for
further discussion. After each round, a summary of the re-
sponses was distributed among panel members. The members
explicitly indicated whether they agreed on the summary of
the responses: the a priori consensus level of 70% was also
used to determine whether the panel agreedwith the summary.
All study communication was via email.
Reporting After the Delphi study was completed and the first
draft of the manuscript was available, members of the panel
who actually participated in the Delphi study were invited to
become a co-author on the present paper. The authors also
reported to the ISBM Board and Governing Council.
Results
Main Results
The final texts on the definition and scope of behavioral med-
icine, its defining characteristics, and the proposal regarding
ISBM’s main tasks and goals can be found in Boxes 1, 2, and
3, respectively. These results were obtained in four rounds of
discussion among the members of the panel, as detailed be-
low.
Box 1 The definition and scope of behavioral medicine
Behavioral medicine is a field of research and practice that builds on
collaboration among multiple disciplines. These disciplines are
concerned with the development and integration of behavioral and
biomedical knowledge relevant to health and disease. Behavioral
knowledge refers to psychosocial, societal, economic, cultural,
existential, and environmental processes of health- and disease-related
behavior, and biomedical knowledge refers to physiological,
pathological, and medical processes. This knowledge is applied to
prevention, health promotion, diagnosis, treatment, rehabilitation, and
care. The scope of behavioral medicine is broadly inclusive of
behavioral and biomedical science as well as clinical and public health
practice.
Delphi Panel and Response Rate
The Delphi panel consisted of 29 people: 6 members of the
core group only, 22 representing an organization (including 3
who were also core group members), and 1 non-voting mod-
erator. The overall response rate in round 1 was 82% (core
group: 78%; representatives: 86%), in round 2: 93% (core
group 100%; representatives: 86%), in round 3: 86% (core
group: 78%; representatives: 95%), and in round 4: 93% (core
group: 100%; representatives: 91%).
Round 1
Consensus was reached for 8 out of 9 items in round 1, with the
percentage of agreement ranging from 83 to 96%. The one
exception concerned the item on the need for a name change:
the agreement on that item was 48%. The ratings are listed in
Supplementary file 3, Table S1. The degree of consensus and
panel member’s comments are summarized below for each
item, followed by the core group’s considerations after round 1.
Item 1. Definition and Scope of Behavioral Medicine The pan-
el reached consensus on the proposed definition and scope of
behavioral medicine (agreement: 87%). Respondents men-
tioned that the explanation of “behavioral knowledge” needs
to be integrated into the definition, as it refers to a broader
understanding of “behavioral” than is usually encountered. In
the listing of processes, use of the term “psychosocial process-
es” was suggested, along with the inclusion of economic and
political processes and environmental influences, thereby em-
phasizing the idea of multiple determinants of health.
Respondents questioned whether “techniques” should be
mentioned, as the term “application of knowledge” is suffi-
cient to convey the practical application of behavioral medi-
cine. The term “methodologies” was suggested as an alterna-
tive to “techniques.” It was alsomentioned that the uniqueness
of behavioral medicine needs to be emphasized: the aim is not
solely to synthesize different perspectives, but to transcend
traditional boundaries and thereby create new knowledge.
The current definition was felt to be too long and difficult to
remember, and several minor edits were proposed. Finally,
single suggestions included not removing “etiology” from
areas where behavioral medicine can be applied, emphasizing
the user perspective, referring to psychophysiology, referring
to health services, and use of the term “inter-professional.”
Item 2. Behavioral Medicine Is a Field and Not a Discipline
The panel reached consensus regarding characterizing behav-
ioral medicine as a field rather than as a discipline (agreement
96%). The panel relied on Sommer’s characterization of the
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difference between a field and discipline [15]: “Discipline.
(…) Members of a discipline have been trained in departments
associated with that discipline and study many different phe-
nomena using a shared epistemology.” (p. 2) “Field of study.
(…) People in a field of study have been trained in various
disciplines and professions but all focus on a common prob-
lem area.” (p. 2) (see Supplementary file 1). Respondents
mentioned that behavioral medicine is frequently thought of
as a discipline and that there is a need to clarify that it is not a
sub-discipline of medicine.
Box 2 Defining characteristics of behavioral medicine
1. Behavioral medicine is a field, and not a discipline.
2. Behavioral medicine’s uniqueness is based on transcending
disciplinary boundaries to create new knowledge or practice.
3. Behavioral medicine is characterized by the interaction of research
(development of knowledge) and practice (professional practice in
clinical and public health).
4. Behavioral medicine is characterized by activities in three domains—
bio-behavioral mechanisms, clinical practice, and public health—and
the interaction of activities in these domains.
Item 3. Behavioral Medicine: Research and Practice There
was consensus concerning the idea that behavioral med-
icine is comprised of both the development of knowl-
edge and techniques (research) and the application of
said knowledge and techniques (practice) (agreement
91%). Several respondents mentioned that the flow of
knowledge between research and practice is not unidi-
rectional; instead, it might be better to discuss “re-
search-practice interactions,” in the sense that research
and practice are linked and inform each other’s devel-
opment. One respondent mentioned that research should
provide evidence that is useful for practice.
Item 4. The Scope of Behavioral Medicine Extends from Bio-
behavioral Mechanisms to Clinical Diagnosis and Intervention
and to Public Health Despite the consensus on scope (agree-
ment 87%), there were several suggestions to improve the
wording in order to avoid suggestion of a unidirectional rela-
tionship implied by the phrasing “extends from .. to ..,” instead
emphasizing the interactions between bio-behavioral mecha-
nisms, clinical diagnosis and intervention, and public health.
There were single suggestions not to refer to clinical diagno-
sis; to de-emphasize public health or not to include public
health at all; to add health services; to add sectors outside
medicine and health care; and to add dissemination.
Item 5. Support and Facilitation of Collaboration Among
Behavioral and Biomedical Disciplines There was consensus
to add facilitation of collaboration among behavioral
and biomedical disciplines to the current tasks and goals
of ISBM (agreement 96%). Several respondents men-
tioned that support and facilitation of collaboration
among behavioral and biomedical disciplines could be-
come the core feature and central part of ISBM’s iden-
tity, with great strategic potential. Specific suggestions
for collaboration were given, such as arranging tracks at
medical, psychological, and behavioral congresses.
I tem 6. Col laborat ion Among Mono-disc ipl inary
Organizations Interested in Activities at the Interface of
Behavior and Biomedicine Despite the consensus that ISBM
could serve as an international platform for collaboration
among mono-disciplinary organizations with interests at the
interface of behavior and biomedicine (agreement 96%), there
were several comments expressing doubts about the need to
add this task: the current listing of tasks and goals may be
sufficient, especially if one adds “support and facilitation of
collaboration among behavioral and biomedical disciplines”
(item 5). It was pointed out that ISBM already has a member-
ship category for “specialized societies” (that is, mono-
disciplinary organizations), but that there has not been much
effort to set up collaborations with such societies.
Item 7. International Platform for Exchange of Activities
Related to Clinical and Public Health Practice There was
consensus to add activities related to practice in clinical
care and public health to ISBM’s current tasks (agree-
ment 83%). It was mentioned that greater clarity is
needed as to exactly how this could be achieved.
Guidelines and policy/practice briefs, education and
training (short professional courses, links to medical
schools), and practice-related special interest groups
were suggested as potentially fruitful activities.
Item 8. International Platform for Multidisciplinary
Collaboration with Regard to Education and Training in
Behavioral Medicine The panel reached consensus on the idea
that ISBM would serve as an international platform for mul-
tidisciplinary collaboration regarding education and training
in behavioral medicine (agreement 96%). In fact, it was noted
that education and training is already a task, and several re-
spondents stated that there was a need to better emphasize this
task.
Item 9. Name Change In response to the question as to wheth-
er ISBM should consider a name change (for example,
International Society of Behavioral Health and Medicine),
no consensus was reached (agreement 48%). Respondents
pointed out that the connotations of “behavioral health” vary
strongly between countries; that “behavioral health” is diffi-
cult to translate in their language; that the term “behavioral
medicine” has been used for some time and is generally ac-
cepted to include all aspects of the current definition; and a
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name change might be confusing. Other respondents support-
ed the suggestion to add “health” to the name, to convey more
explicitly ISBM’s broad and multidisciplinary community,
and to emphasize that behavioral medicine is not a sub-
discipline of medicine. Some respondents stated that national
or regional societies can include behavioral health in their own
name. Another suggestion was to include “science” in the
name (for example, International Society of Behavioral
Science in Health Care and Medicine).
Box 3 Proposal on the main tasks and goals of ISBM
Communication, collaboration, and liaison
• To support and facilitate communication and collaboration among
behavioral and biomedical disciplines
• To encourage the organization of scientific meetings related to
behavioral medicine, at the national, regional, and international levels
• To encourage the publication and dissemination of scientific
information on behavioral medicine, with an emphasis on international
impact
• To maintain liaison with related scientific societies and networks, and
with related international, professional, and policy organizations
Research
• To stimulate research in the field of behavioral medicine, with an
emphasis on the international collaborative level
Education
• To stimulate education and training activities related to behavioral
medicine, in particular the development of curricula, materials,
workshops, and courses
Practice
• To raise the profile of behavioral medicine and to serve as an
information source on activities in the field of behavioral medicine
• To serve as an international platform for activities in clinical and public
health practice
• To stimulate the development of standards, guidelines, and
practice/policy briefs on behavioral medicine
Support
• To encourage the formation of national or regional organizations for
behavioral medicine
• To support and recognize scientists working in behavioral medicine,
with an emphasis on—but not limited to—professionals at an early
stage of their career
Additional Comments A further suggestion was to add “en-
hancing visibility of the field to the general public” and “rais-
ing the profile of behavioral medicine, with a focus on public
health policymakers and medical educators” to the current
tasks.
The Core Group’s Considerations Following Round 1
Definition and Scope In response to the suggestions from the
Delphi panel, the core group proposed the following: adding
an explanation of “behavioral knowledge” to the definition;
combining psychological and social into “psychosocial” pro-
cesses; adding economic processes; considering political pro-
cesses as a category of societal processes; removing references
to “techniques”; and adopting some of the proposed edits on
the definition and scope.
Defining Characteristics The core group noted consensus on
four defining characteristics of behavioral medicine. First,
behavioral medicine is a field and not a discipline.
Behavioral medicine is a field arising from the collaboration
of people with a scientific background in behavioral disci-
plines (concerned with psychosocial, societal, economic, cul-
tural, existential, and environmental phenomena) and biomed-
ical disciplines (concerned with phenomena in the physiolog-
ical, pathological, or medical domain). Second, transcending
disciplinary boundaries to create new knowledge or practice is
a defining characteristic of behavioral medicine. The core
group agreed that transdisciplinary and inter-professional col-
laboration is not exclusively about synthesizing different per-
spectives; instead, the intention is to transcend disciplinary
boundaries to create new knowledge or practice. Third, behav-
ioral medicine is characterized by the interaction of research
(development of knowledge) and practice (professional prac-
tice in clinical and public health). Research and practice inter-
act and can mutually inform each other’s development.
Fourth, behavioral medicine is characterized by activities in
three domains—bio-behavioral mechanisms, clinical practice,
and public health—and the interaction of activities in these
domains. The translation of findings in one of these domains
into the other domains contributes significantly to the success-
ful development of the field as a whole. There is a need for
balanced development and representation of all three
domains.
Main Tasks and Goals The core group agreed that “support and
facilitation of collaboration among behavioral and biomedical
disciplines” could be a key point when defining ISBM’s main
tasks and goals. This task can be combined with the current
task of enhancing interdisciplinary communication. It was
agreed that there is no need to separately mention “collabora-
tion among mono-disciplinary organizations interested in ac-
tivities at the interface of behavior and biomedicine.”
However, it was stressed that collaboration with mono-
disciplinary organizations should be strongly encouraged.
The core group agreed to add “creating an international plat-
form for activities related to clinical and public health prac-
tice” to the tasks and goals. It was agreed that although “edu-
cation and training” is already included, there is a real need to
emphasize this task. The core group also agreed to add “rais-
ing the profile of behavioral medicine” to the tasks and goals;
target groups include public health policymakers, medical ed-
ucators, the general public, and other relevant groups. Finally,
the core group noted that it would not be possible to simply
add new tasks and goals to the current ones (see
Supplementary file 4), as this would result in a poorly struc-
tured text. They agreed on the need to rewrite the tasks and
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goals, and that the Delphi panel should be invited to rate the
proposal on the tasks and goals.
Name Change The core group acknowledged various pros and
cons regarding a name change. The connotations of “behav-
ioral health” vary between countries, and a name change
might be confusing. On the other hand, adding “health” to
the name could more explicitly convey ISBM’s broad and
multidisciplinary community and emphasize that behavioral
medicine is not a sub-discipline of medicine. Weighing these
arguments, the core group proposed retaining the current
name, but to encourage national and regional societies to se-
lect a name that reflects their needs and purposes, and to em-
phasize in communications that ISBM is a broad and multi-
disciplinary community. It was decided that the Delphi panel
should be invited to rate the proposal not to change the
society’s name, and to provide comments.
Round 2
The core group defined 3 items for discussion in round 2.
Consensus was reached for all 3 items, with the percentage
of agreement ranging from 81 to 96%. The ratings are listed in
Supplementary file 3, Table S2. The panel provided further
comments.
Item 1. The Definition and Scope of Behavioral Medicine, and
Its Defining Characteristics The panel reached consensus on
the proposed definition, scope, and defining characteristics of
behavioral medicine (agreement 92%). Respondents sug-
gested further emphasizing “psychosocial” by referring to bio-
medical, psychosocial, and behavioral knowledge, or con-
versely, not to use the term “psychosocial” at all.
Respondents mentioned that the definition is still difficult to
remember and suggested shortening it. The panel suggested
several edits to improve the wording.
Item 2. Tasks and Goals The panel reached consensus on the
proposed tasks and goals of ISBM (agreement 96%).
Suggestions included explicitly adding collaboration with oth-
er organizations and providing more detail on “research.” The
panel suggested several edits to improve the wording.
Item 3. Proposal Not to Change the Name Although the con-
sensus was not to change the society’s name (agreement
81%), several panelists emphasized the need to improve the
society’s appeal to non-clinicians. Adding a tagline to the
name was suggested as a means to convey additional infor-
mation that is not immediately evident when hearing the so-
ciety name. One suggestion was to include “science” in the
society’s name. The need to clarify the distinction between
behavioral medicine and other fields and disciplines was also
mentioned. The panel suggested several edits to improve the
wording.
The Core Group’s Considerations Following Round 2
The core group agreed to add collaboration with other orga-
nizations to the tasks and goals, and to make several edits to
improve the wording. The core group decided to ask for the
panel’s opinion on adding a tagline to the society name, and to
request suggestions regarding a tagline. The group considered
a discussion on the distinction between behavioral medicine
and other fields and disciplines as beyond the scope of its
mandate, but it was suggested that a follow-up project could
focus on that distinction.
Round 3
The core group defined 1 item for discussion in round 3, on
the need to add a tagline to the society’s name. Consensus was
reached to add a tagline (agreement 88%). The suggestions
and ratings for a specific tagline are listed in Supplementary
file 3, Table S3.
The Core Group’s Considerations Following Round 3
The core group decided not to vote on a specific tagline, bear-
ing in mind that this decision should be based on ISBM’s
communication strategy and specialized expertise in commu-
nication. Instead, the tagline suggestions were forwarded to
ISBM with a recommendation for further decision-making on
this issue. In addition, the wording of the definition of behav-
ioral medicine was improved, by splitting the first, rather long
sentence into two sentences.
Round 4
One of the reviewers of the first version of the present paper
expressed concern that the explanation of “behavioral knowl-
edge” did not include behavioral processes, which resulted in
a very broad definition. The core group agreed with this com-
ment and proposed to amend the explanation of “behavioral
knowledge” as follows: “behavioral knowledge refers to psy-
chosocial, societal, economic, cultural, existential and envi-
ronmental processes of health- and disease-related behavior,”
with the understanding that health- and disease-related behav-
ior refers to overt behavior (e.g., physical activity) as well as
related cognition, emotion, and motivation. The panel reached
consensus on this amendment (agreement 100%). The ratings
are listed in Supplementary file 3, Table S4.
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Discussion
The international panel reached consensus on an updated def-
inition and scope of behavioral medicine and its four defining
characteristics, and on a proposal regarding ISBM’s main
tasks and goals. The international panel consisted of experts
in the field, representatives of ISBM member societies,
ISBM’s early career network, and several emerging collabo-
rative groups in the field of behavioral medicine. As the re-
sponse rates and the degrees of consensus were high (well
above 80% and well above the a priori defined criterion of
70%, respectively), there appears to be strong support for the
present proposals.
The original definition of behavioral medicine by Schwartz
and Weiss [1] and the scope of behavioral medicine in the
ISBM Charter [5] are clearly still relevant. However, the ex-
planation of “behavioral knowledge” is an important differ-
ence between the updated and original definition. The updated
definition uses a broad understanding of “behavioral knowl-
edge,” referring to psychosocial, societal, economic, cultural,
existential, and environmental processes of health- and
disease-related behavior, with the understanding that health-
and disease-related behavior refers to overt behavior (e.g.,
physical activity) as well as related cognition, emotion, and
motivation. Another difference is the emphasis on “research
and practice.” The flow of knowledge between research and
practice is not unidirectional, from research to practice.
Instead, research and practice are linked, and they mutually
inform each other’s development: research findings are imple-
mented in clinical and public health practice, while experi-
ences in practice lead to innovations in research. Other differ-
ences between the original and updated definitions include the
addition of “health promotion” and “care” as areas where be-
havioral medicine is being applied, in addition to several
rewordings. Finally, the definition in the ISBM Charter [5]
refers to “etiology” as an area where behavioral medicine is
being applied. In the updated definition, etiology was deleted
because etiology is not an area where knowledge is being
applied: etiology is not an intervention [7] (Supplementary
file 1). This does not mean that etiology is not important. On
the contrary, behavioral factors are very important in the eti-
ology of disease: this is being studied under “bio-behavioral
mechanisms.”
The four defining characteristics provide further clar-
ification and explanation of the definition of behavioral
medicine. Importantly, these four characteristics provide
clear guidance on the tasks and goals of ISBM: (i)
Behavioral medicine is a field (and not a specific disci-
pline). Consequently, facilitating and promoting commu-
nication and collaboration between behavioral and bio-
medical disciplines is a key task of ISBM, and ISBM
should promote communication and collaboration be-
tween these disciplines in research, education, and
practice. (ii) In doing so, the focus should be on
transcending traditional disciplinary boundaries to create
new knowledge or practice, instead of just synthesizing
different perspectives. (iii) Behavioral medicine is char-
acterized by the interaction of research and practice.
Consequently, ISBM should facilitate the exchange of
information between research and practice. ISBM should
also maintain links with related international, profession-
al, and policy organizations, and it should serve as an
international platform for exchange of activities in clin-
ical and public health practice. (iv) Finally, behavioral
medicine is characterized by activities in three domains:
bio-behavioral mechanisms, clinical practice, and public
health. Therefore, ISBM should encourage productive
exchange and collaboration between these domains in
its activities related to meetings and publications, re-
search, education, practice, and support.
The diverging perspectives on the need for a name change
did not come as a surprise: discussions on name changes tend
to be long and difficult. However, it should be noted that this
discussion touched upon crucial issues. Most importantly,
transcending disciplinary boundaries is a key characteristic
of behavioral medicine. In behavioral medicine, various dis-
ciplines interact on an equal footing; this is crucial for suc-
cessful collaboration and the development of truly innovative
research and practice. On the other hand, the connotations of
“behavioral health” vary strongly between countries, which
make it a less desirable term. While it has been clearly stated
that “behavioral medicine” is not a sub-discipline within med-
icine, it seems important to add a tagline to the Society’s name
to convey that information. In that respect, including terms
such as “transcending disciplinary boundaries” and “health”
in the tagline is key. Further decision-making could be em-
bedded in a future ISBM communication strategy, elaborating
on the various suggestions on a tagline generated by the panel
(see Supplementary file 3, Table S3).
The discussion on the name change and on main tasks
and goals both focused on ISBM. It should be noted,
however, that these discussions have implications for
the entire field of behavioral medicine, not only for
ISBM. The name change would have applied to the en-
tire field, not only the society. The tasks and goals are
for ISBM as the umbrella organization in the field.
Although it is a limitation of the present study that this
broader perspective was not clearly mentioned in the
discussion paper and the questions, it can be assumed
that the panel was aware of this broader perspective.
The present study adds substantially to our earlier
work [6, 7]. The explanation of “behavioral knowledge”
has been improved; the interaction between research and
practice has been emphasized, with research and practice
mutually informing each other; and the four main char-
acteristics of behavioral medicine have been clearly
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stated. The proposal on ISBM’s main tasks and goals
was derived from the four main characteristics—this is
entirely novel work. Finally, the definition, main charac-
teristics, and main tasks and goals are all based on a
solid international consensus obtained in a rigorous
Delphi study, as opposed to informal consensus among
a small group of authors [6, 7].
The field of behavioral medicine is evolving. Future devel-
opments may include greater emphasis not only on bioinfor-
matics, artificial intelligence, and environmental science, but
also on ethics and other disciplines. Collaboration with these
disciplines may contribute to knowledge relevant to health
and disease. In the future, the definition of behavioral medi-
cine may have to be expanded to include these disciplines.
Other future developments could include elaborating on the
main characteristics of behavioral medicine (e.g., more em-
phasis on transcending disciplinary boundaries to create new
knowledge or practice) or more emphasis on specific topics
(e.g., prevention of infectious diseases).
Through a truly international discussion, consensus
was reached on an updated definition and scope of be-
havioral medicine, and its defining characteristics, and on
a proposal regarding ISBM’s main tasks and goals. The
expanding reach of behavioral medicine renders crucial
the need to develop a current and comprehensive defini-
tion, as well as characterization of scope and priorities.
Our discussions have informed an update to the defini-
tion and scope of behavioral medicine and its defining
characteristics, and provided guidance on ISBM’s main
tasks and goals to help align with contemporary global
perspectives. For the further development of the field of
behavioral medicine and ISBM as the umbrella organiza-
tion in that field, it is critical to generate clarity in terms
of the definition and scope of our discipline and to de-
lineate priorities for cultivating engagement and multidis-
ciplinary collaboration at an international level. The
work described herein provides a foundational step to-
ward achieving these goals for ISBM and its member
organizations.
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